Pfizer INC Form 4 insider transactions

Director Shantanu Narayen reports acquisition of phantom stock units representing deferred director's compensation.

Director Joseph Echevarria reports acquisition of phantom stock units representing deferred director's compensation in a recent SEC filing.

Director Cyrus Taraporevala reports acquiring phantom stock units in Pfizer Inc. through deferred compensation.

Executive Vice President Rady A. Johnson reports acquiring phantom stock units in Pfizer through the Supplemental Savings Plan.

Jennifer B. Damico, SVP & Controller at Pfizer, reported the acquisition of 54 phantom stock units through the Pfizer Supplemental Savings Plan on June 28, 2024.

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 19 phantom stock units through the company's Supplemental Savings Plan.

Jennifer B. Damico, SVP & Controller at Pfizer Inc., reported the acquisition of phantom stock units through the Pfizer Supplemental Savings Plan.

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 19 phantom stock units through the company's Supplemental Savings Plan.

Jennifer B. Damico, SVP & Controller at Pfizer Inc., reported the acquisition of 49 phantom stock units through the Pfizer Supplemental Savings Plan on May 31, 2024.

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 18 phantom stock units through the company's Supplemental Savings Plan on May 31, 2024.

Pfizer's Chief Financial Officer, David M. Denton, reported a transaction involving the withholding of shares to cover tax obligations upon the vesting of restricted stock units.

Jennifer B. Damico, SVP & Controller of Pfizer Inc., reported the acquisition of 49 phantom stock units through the Pfizer Supplemental Savings Plan on May 15, 2024.

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 18 phantom stock units through the Pfizer Supplemental Savings Plan on May 15, 2024.

Jennifer B. Damico, SVP & Controller at Pfizer, reports the acquisition of 55 phantom stock units through the Pfizer Supplemental Savings Plan.

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 20 phantom stock units through the Pfizer Supplemental Savings Plan on April 30, 2024.

Director James Quincey reports acquisition of phantom stock units as deferred compensation.

Director James C. Smith reports acquiring phantom stock units in Pfizer, Inc. through a nonfunded deferred compensation plan.

Director Suzanne Nora Johnson reports the acquisition of phantom stock units in Pfizer Inc. as part of deferred compensation.

Director Shantanu Narayen reports acquiring phantom stock units in Pfizer, according to a Form 4 filing with the SEC.

Director Susan Hockfield acquired 8,115.598 phantom stock units of Pfizer Inc. as part of a deferred compensation plan.

Director Dan R. Littman reports acquisition of phantom stock units in Pfizer Inc. through a nonfunded deferred compensation plan.

Director Helen Hobbs reports acquiring phantom stock units in Pfizer through a nonfunded deferred compensation plan.

Director Scott Gottlieb reported the acquisition of phantom stock units in Pfizer, according to a Form 4 filing with the SEC.

Director Joseph Echevarria reports acquisition of phantom stock units in Pfizer Inc. through a non-funded deferred compensation plan.

Director Susan Desmond-Hellmann reports acquisition of 8,115.598 phantom stock units of Pfizer, Inc. as deferred compensation.

Director Ronald E. Blaylock reports acquisition of phantom stock units as deferred compensation from Pfizer Inc.

Jennifer B. Damico, SVP & Controller at Pfizer Inc., reported the acquisition of 54 phantom stock units through the Pfizer Supplemental Savings Plan on April 15, 2024.

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 20 phantom stock units through the company's Supplemental Savings Plan on April 15, 2024.

Jennifer B. Damico, SVP & Controller of Pfizer Inc., reports the acquisition of 108 phantom stock units through the Pfizer Supplemental Savings Plan.

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 18 phantom stock units through the company's Supplemental Savings Plan on April 10, 2024.